Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion

Stock Track

04/20

4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.

The sharp rise appears to be driven by multiple positive developments announced just before the trading session. The company received UKCA certification for its Ct:Vq product for clinical use in the United Kingdom, executed a contract with pharmaceutical giant GlaxoSmithKline for lung imaging analytics, and is reportedly being considered for inclusion in the ASX 200 index.

These developments represent significant milestones for 4DMedical, potentially expanding its market reach in the UK, securing a major commercial partnership with GSK, and gaining increased visibility through potential index inclusion.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1144016744"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144016744\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144016744?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-20 08:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144016744","market":"hk","top_or_hot":-1,"title":"Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion","media":"Stock Track","content":"<p>4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.</p><p>The sharp rise appears to be driven by multiple positive developments announced just before the trading session. The company received UKCA certification for its Ct:Vq product for clinical use in the United Kingdom, executed a contract with pharmaceutical giant GlaxoSmithKline for lung imaging analytics, and is reportedly being considered for inclusion in the ASX 200 index.</p><p>These developments represent significant milestones for 4DMedical, potentially expanding its market reach in the UK, securing a major commercial partnership with GSK, and gaining increased visibility through potential index inclusion.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-04-20 08:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.</p><p>The sharp rise appears to be driven by multiple positive developments announced just before the trading session. The company received UKCA certification for its Ct:Vq product for clinical use in the United Kingdom, executed a contract with pharmaceutical giant GlaxoSmithKline for lung imaging analytics, and is reportedly being considered for inclusion in the ASX 200 index.</p><p>These developments represent significant milestones for 4DMedical, potentially expanding its market reach in the UK, securing a major commercial partnership with GSK, and gaining increased visibility through potential index inclusion.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"4DX.AU","symbol_name":"4DMEDICAL LTD","start_time":0,"source_url":"","article_id":"1144016744","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144016744","pubTimestamp":1776643397,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.The sharp rise appears to be driven by multiple...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"4DX.AU":"4DMEDICAL LTD"},"translate_title":"个股追踪|GSK合约、英国认证、ASX 200纳入4DMedical盘中大涨8.22%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"4DX.AU":1},"content_text":"4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.The sharp rise appears to be driven by multiple positive developments announced just before the trading session. The company received UKCA certification for its Ct:Vq product for clinical use in the United Kingdom, executed a contract with pharmaceutical giant GlaxoSmithKline for lung imaging analytics, and is reportedly being considered for inclusion in the ASX 200 index.These developments represent significant milestones for 4DMedical, potentially expanding its market reach in the UK, securing a major commercial partnership with GSK, and gaining increased visibility through potential index inclusion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}